Merck (NYSE:MRK) experienced a 13% increase in its stock price over the last month, aided by several significant developments. The company's upcoming presentations at the American College of ...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...
Edinburgh, a city in Scotland, will be the starting point for the 2027 Tour de France, which will be returning to Britain for ...
AstraZeneca signed a deal with Alteogen worth up to $1.35 billion for subcutaneous cancer drugs. Taiho Pharmacetical bought ...
Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...
The Motley Fool on MSN6d
Down 93%, Is It Finally Time to Buy Moderna?In addition to its COVID-19 vaccine, Moderna markets an RSV vaccine that earned ... Moderna is developing an individualized ...
The White House is reportedly considering former U.S. Rep. Michael Burgess (R-Texas) as its nominee to head the CDC. Burgess, ...
AZoLifeSciences on MSN1d
What Will the Life Sciences Industry Look Like in 2030?The future of the life sciences industry hinges on AI and automation, driving innovation in drug discovery and addressing ...
Conduent Incorporated , a global technology-driven business solutions and services company, today announced that the Republic of Ireland's Health Service Executive (HSE) selected the company's Maven® ...
Drugmakers are urging the Trump administration and European Union officials to exempt medical goods from widening tariff wars, hoping to avert an ...
president of Merck Research Laboratories, told the meeting that cardiovascular disease is a big opportunity as it remains an epidemic, killing 35 million people during the pandemic while COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback